Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · November 20, 2023

Real-World Impact of (Neo)/Adjuvant Anti-HER2 Treatment on the Characteristics and Outcomes in Women With HER2+ Metastatic Breast Cancer

The Oncologist


Additional Info

The Oncologist
Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program
Oncologist 2023 Oct 03;28(10)e867-e876, F Le Du, M Carton, T Bachelot, M Saghatchian, B Pistilli, E Brain, D Loirat, L Vanlemmens, T Vermeulin, G Emile, A Gonçalves, M Ung, M Robert, A Jaffre, I Desmoulins, C Jouannaud, L Uwer, J Marc Ferrero, MA Mouret-Reynier, W Jacot, M Chevrot, S Delaloge, V Diéras

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading